NO160412C - Inert matrise basert paa polykaprolakton for oral administrasjon av et legemiddel, og fremgangsmaate for fremstillingav den galeniske form omfattende denne matrise. - Google Patents

Inert matrise basert paa polykaprolakton for oral administrasjon av et legemiddel, og fremgangsmaate for fremstillingav den galeniske form omfattende denne matrise.

Info

Publication number
NO160412C
NO160412C NO845273A NO845273A NO160412C NO 160412 C NO160412 C NO 160412C NO 845273 A NO845273 A NO 845273A NO 845273 A NO845273 A NO 845273A NO 160412 C NO160412 C NO 160412C
Authority
NO
Norway
Prior art keywords
matrix
preparation
polycaprolakton
medicine
procedure
Prior art date
Application number
NO845273A
Other languages
English (en)
Norwegian (no)
Other versions
NO160412B (no
NO845273L (no
Inventor
Herve Grouiller
Fabien Christ
Original Assignee
Lhd Lab Hygiene Dietetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lhd Lab Hygiene Dietetique filed Critical Lhd Lab Hygiene Dietetique
Publication of NO845273L publication Critical patent/NO845273L/no
Publication of NO160412B publication Critical patent/NO160412B/no
Publication of NO160412C publication Critical patent/NO160412C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Materials For Medical Uses (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
NO845273A 1984-01-02 1984-12-28 Inert matrise basert paa polykaprolakton for oral administrasjon av et legemiddel, og fremgangsmaate for fremstillingav den galeniske form omfattende denne matrise. NO160412C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8400015A FR2557459B1 (fr) 1984-01-02 1984-01-02 Matrice inerte a base de polycaprolactone pour administration orale d'un medicament, et procede de preparation de la forme galenique comprenant cette matrice

Publications (3)

Publication Number Publication Date
NO845273L NO845273L (no) 1985-07-03
NO160412B NO160412B (no) 1989-01-09
NO160412C true NO160412C (no) 1989-04-19

Family

ID=9299789

Family Applications (1)

Application Number Title Priority Date Filing Date
NO845273A NO160412C (no) 1984-01-02 1984-12-28 Inert matrise basert paa polykaprolakton for oral administrasjon av et legemiddel, og fremgangsmaate for fremstillingav den galeniske form omfattende denne matrise.

Country Status (23)

Country Link
US (1) US4629624A (hu)
EP (1) EP0147335B1 (hu)
JP (1) JPS60185729A (hu)
KR (1) KR850005271A (hu)
AT (1) ATE33553T1 (hu)
AU (1) AU574024B2 (hu)
CA (1) CA1238856A (hu)
CS (1) CS247190B2 (hu)
DD (1) DD235829A5 (hu)
DE (1) DE3470459D1 (hu)
DK (1) DK616084A (hu)
ES (1) ES8605682A1 (hu)
FI (1) FI79942C (hu)
FR (1) FR2557459B1 (hu)
GR (1) GR82607B (hu)
HU (1) HU193731B (hu)
IL (1) IL73957A (hu)
NO (1) NO160412C (hu)
OA (1) OA08018A (hu)
PH (1) PH22167A (hu)
PT (1) PT79786B (hu)
YU (1) YU223884A (hu)
ZA (1) ZA857B (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU86077A1 (fr) * 1985-09-18 1987-04-02 Pharlyse Sa Nouvelles formes galeniques du verapamil,leur fabrication et medicaments contenant ces nouvelles formes galeniques
DE3701625A1 (de) * 1987-01-21 1988-08-04 Boehringer Ingelheim Kg Perorale arzneimittelzubereitung mit verzoegerter wirkstofffreigabe
SE8701479L (sv) * 1987-04-09 1988-10-10 Carbomatrix Ab Metod foer inneslutning av biologiskt verksamma preparat samt anvaendning daerav
FR2627696B1 (fr) * 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
GB8805286D0 (en) * 1988-03-05 1988-04-07 Schering Agrochemicals Ltd Trypanocides
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
FR2791569B1 (fr) * 1999-03-31 2003-05-09 Pf Medicament Composition ou structure microporeuse expansee isotrope a dissolution rapide a usage pharmaceutique, veterinaire, dietetique, alimentaire ou cosmetique et son procede d'obtention
US6531158B1 (en) 2000-08-09 2003-03-11 Impax Laboratories, Inc. Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
KR20060085682A (ko) * 2003-10-10 2006-07-27 라이프사이클 파마 에이/에스 피브레이트 및 스타틴을 함유하는 고형 제제
EP1680091B1 (en) * 2003-10-10 2017-05-31 Veloxis Pharmaceuticals A/S A solid dosage form comprising a fibrate
US9173847B2 (en) * 2003-10-10 2015-11-03 Veloxis Pharmaceuticals A/S Tablet comprising a fibrate
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
FR2912751B1 (fr) * 2007-02-16 2012-07-13 Arkema France Procede de preparation de polylactones et polylactames
FR2912752B1 (fr) * 2007-02-16 2012-10-05 Arkema France Procede de preparation d'un copolymere d'au moins un monomere cyclique
WO2010032128A1 (en) * 2008-09-18 2010-03-25 Purdue Pharma L.P. Pharmaceutical dosage forms comprising poly(e-caprolactone)
AU2013203747B2 (en) * 2008-09-18 2016-01-07 Purdue Pharma L.P. Pharmaceutical dosage forms comprising poly(e-caprolactone)
TW201336529A (zh) * 2011-12-09 2013-09-16 Purdue Pharma Lp 包含聚（ε－己內酯）和聚氧化乙烯之藥物劑量型

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1490855A (fr) * 1965-08-27 1967-08-04 Shell Int Research Procédé pour la fabrication d'articles en polyesters provenant de la polymérisation des lactones
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US3929937A (en) * 1972-07-28 1975-12-30 Union Carbide Corp Biodegradable shaped articles from a material comprising a particulate addition polymer in a matrix of a thermoplastic oxyalkanoyl polymer
US4095791A (en) * 1976-08-23 1978-06-20 Fairchild Camera And Instrument Corp. Cartridge programmable video game apparatus
FR2377431A1 (fr) * 1977-01-12 1978-08-11 Inst Sint Smol Procede de preparation de materiaux polymeres a pores ouverts
FR2397840B1 (hu) * 1977-07-22 1981-03-20 Cherqui Jean
US4148871A (en) * 1977-10-11 1979-04-10 Pitt Colin G Sustained subdermal delivery ofdrugs using poly(ε-caprolactone) and its copolymers

Also Published As

Publication number Publication date
FI845088A0 (fi) 1984-12-21
ES8605682A1 (es) 1986-04-01
ATE33553T1 (de) 1988-05-15
EP0147335A2 (fr) 1985-07-03
EP0147335B1 (fr) 1988-04-20
FI79942C (fi) 1990-04-10
AU574024B2 (en) 1988-06-23
HU193731B (en) 1987-11-30
PT79786A (fr) 1985-02-01
FI845088L (fi) 1985-07-03
OA08018A (fr) 1987-01-31
AU3720984A (en) 1985-07-11
CS247190B2 (en) 1986-12-18
DK616084A (da) 1985-07-03
GR82607B (en) 1985-02-11
KR850005271A (ko) 1985-08-24
FI79942B (fi) 1989-12-29
CA1238856A (en) 1988-07-05
JPS60185729A (ja) 1985-09-21
FR2557459B1 (fr) 1986-05-30
ZA857B (en) 1985-08-28
DE3470459D1 (en) 1988-05-26
FR2557459A1 (fr) 1985-07-05
YU223884A (en) 1987-10-31
PT79786B (fr) 1986-10-28
ES539187A0 (es) 1986-04-01
IL73957A (en) 1988-02-29
NO160412B (no) 1989-01-09
US4629624A (en) 1986-12-16
PH22167A (en) 1988-06-28
IL73957A0 (en) 1985-03-31
DD235829A5 (de) 1986-05-21
EP0147335A3 (en) 1985-07-31
NO845273L (no) 1985-07-03
HUT37567A (en) 1986-01-23
DK616084D0 (da) 1984-12-20

Similar Documents

Publication Publication Date Title
NO845273L (no) Inert matrise basert paa polykaprolakton for oral administrasjon av et legemiddel, og fremgangsmaate for fremstilling av den galeniske form omfattende denne matrise
FI884636A0 (fi) Pitkävaikutteisen farmaseuttisen valmisteen valmistusmenetelmä
NO880182L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,2-dihydro-3h-indazol-3-on-derivater.
EP0358150A3 (en) Use of 5-(4-chlorophenyl)-2,4-dimethyl-3h-1,2,4-triazole-3-thione for preparing drugs for the treatment of thrombocytosis
NO171641C (no) Analogifremgangsmaate for fremstilling av 6-substituert-2',3'-dideoksynukleosider
HUT54358A (en) Process for producing substituted 1,3,5-triazinetrione derivatives and medical compositions comprising such compounds as active ingredient
AU6808190A (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
NZ223865A (en) 3'-azido or fluoro-2',3'-dideoxyribofuranosyl derivatives and pharmaceutical compositions therefrom
IT9020020A0 (it) "n,n'-ditrimetossibenzoilpiperazine 2-sostituite, procedimento per la loro preparazione e composizioni terapeutiche che le contengono
EP0365678A4 (en) 2,5,6,7-TETRANOR-4,8-INTER-m-PHENYLENE 2-PGI DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF.
NO881768D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner.
ZA876182B (en) 2.3-dihydrofuran derivatives,process for preparing them,and their use as an intermediate for the preparation of tetrahydrofuran derivatives
ES8205218A1 (es) Un procedimiento para la preparacion de pirrolilpiperidinas utiles como agentes antidepresivo.
IT8721683A0 (it) Procedimento per la reidratazione rapida di legumi e simili, nonche'apparecchiatura per la reidratazione rapida ed in continuov di legumi e simili.
ES8502437A1 (es) Procedimiento para la obtencion del 1-(2,3-dihidro-1,4-benzodioxin-2s-il)-5-(2,3-dihidro-1,4-benzodioxin-2r-il)-3-azapentan-1r-5s-diol.
IT8721798A0 (it) 1,4-diidropiridine 2-alchil- ed alchenil-sostituite, metodo per laloro preparazione e compisizione farmaceutiche che le contengono.
NO164244C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 6,6-ethylen-15,16-methylen-3-oxo-17alfa-pregn-4-en-21,17- carbolactoner.
NO913457L (no) Fremgangsmaate for fremstilling av 2',3'-dideoksy-2',3'-didehydronukleosider.
NO913456D0 (no) Fremgangsmaate for fremstilling av 2',3'-dideoksy-2',3'-didehydronukleosider.
NO913458L (no) Fremgangsmaate for fremstilling av 2',3'-dideoksy-2',3'-didehydronukleosider.
NO913459D0 (no) Fremgangsmaate for fremstilling av 2',3'-dideoksy-2',3'-didehydronukleosider.